materiaux

A Ludwig Cancer Research study has developed a novel nanotechnology that triggers potent therapeutic anti-tumor immune responses and demonstrated its efficacy in mouse models of multiple cancers. Led by Co-director Ralph Weichselbaum, investigator Wenbin Lin and postdoctoral researcher Kaiting Yang at the Ludwig Center at Chicago, the study describes the synthesis, mechanism of action and preclinical assessment of the nanoparticle, which is loaded with a drug that activates a protein central to the efficient induction of anti-cancer immunity.

A team of researchers has discovered a new mechanism to stabilize the lithium metal electrode and electrolyte in lithium metal batteries. This new mechanism, which does not depend on the traditional kinetic approach, has potential to greatly enhance the energy density — the amount of energy stored relative to the weight or volume — of batteries.